Park Y S, Lee S H, Lim C K, Choi H W, An J H, Park C W, Lee H S, Lee J S, Seo J T
Laboratory of Reproductive Medicine, Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea.
Division of Developmental Biology and Physiology, School of Biosciences and Chemistry, Sungshin Women's University, Seoul, Korea.
Andrologia. 2018 Mar;50(2). doi: 10.1111/and.12864. Epub 2017 Jul 13.
This study was performed to evaluate the independent influence of paternal age affecting embryo development and pregnancy using testicular sperm extraction (TESE)-intracytoplasmic sperm injection (ICSI) in obstructive azoospermia (OA) and nonobstructive azoospermia (NOA). Paternal patients were divided into the following groups: ≤30 years, 31-35 years, 36-40 years, 41-45 years and ≥46 years. There were no differences in the rates of fertilisation or embryo quality according to paternal and maternal age. However, clinical pregnancy and implantation rates were significantly lower between those ≥46 years of paternal age compared with other age groups. Fertilisation rate was higher in the OA than the NOA, while embryo quality, pregnancy and delivery results were similar. Clinical pregnancy and implantation rates were significantly lower for patients ≥46 years of paternal age compared with younger age groups. In conclusion, fertilisation using TESE in azoospermia was not affected by the independent influence of paternal age; however, as maternal age increased concomitantly with paternal age, rates of pregnancy and delivery differed between those with paternal age <41 years and ≥46 years. Therefore, paternal age ≥46 years old should be considered when applying TESE-ICSI in cases of azoospermia, and patients should be advised of the associated low pregnancy rates.
本研究旨在评估在梗阻性无精子症(OA)和非梗阻性无精子症(NOA)患者中,采用睾丸精子提取(TESE)-卵胞浆内单精子注射(ICSI)时,父亲年龄对胚胎发育和妊娠的独立影响。将父亲患者分为以下几组:≤30岁、31 - 35岁、36 - 40岁、41 - 45岁和≥46岁。根据父母年龄,受精率或胚胎质量没有差异。然而,与其他年龄组相比,父亲年龄≥46岁的患者临床妊娠率和着床率显著降低。OA患者的受精率高于NOA患者,而胚胎质量、妊娠和分娩结果相似。与年轻年龄组相比,父亲年龄≥46岁的患者临床妊娠率和着床率显著降低。总之,无精子症患者采用TESE受精不受父亲年龄的独立影响;然而,随着母亲年龄与父亲年龄同步增加,父亲年龄<41岁和≥46岁的患者妊娠率和分娩率有所不同。因此,在无精子症患者中应用TESE-ICSI时应考虑父亲年龄≥46岁,并应告知患者相关的低妊娠率。